Breast medicine Flashcards

1
Q

What are fibroadenomas

A

common benign tumours of stromal/ epithelial breast duct tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What age range is most commonly affected by fibroadenomas

A

age 20-40 (typically <30)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Give 5 features of fibroadenomas

A
  • small and discrete
  • non-tender/ painless
  • firm
  • smooth
  • highly mobile breast lump (breast mouse)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When are surgical excisions done for breast fibroadenomas

A

if they are >3cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What causes fibroadenosis (fibrocystic disease)

A
  • connective tissue, ducts and lobules of the breast respond to oestrogen and progesterone, becoming fibrous and cystic
  • these changes fluctuate with the menstrual cycle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give 4 features of fibroadenosis

A
  • lumpy breasts
  • breast pain or tenderness
  • symptoms may worsen prior to menstruation
  • fluctuation of breast size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the features of a breast cyst

A
  • smooth discrete lump
  • mobile
  • may be fluctuant (variable, unstable)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are breast cysts managed

A
  • cysts should be aspirated
  • those which are blood stained or persistently refill should be biopsied or excised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is ductal papilloma

A

warty lesion that grows within one of the ducts in the breast due to epithelial proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the presentation of ductal papillomas

A
  • nipple discharge: clear or blood-stained from a single duct
  • tenderness or pain
  • If large, may present with a mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How are ductal papillomas treated

A

microdochectomy - duct excision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is breast fat necrosis

A

benign lump formed by localised degeneration and scarring of fat tissue in the breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give 3 triggers for breast fat necrosis

A
  • localised trivial/ unnoticed trauma
  • radiotherapy
  • surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which group of women are at a higher risk for developing breast fat necrosis

A

obese women with large breasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does breast fat necrosis typically present

A
  • painless
  • typically firm initially and may develop into a hard and irregular lump
  • lump fixed in local structures
  • nipple inversion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What imaging techniques can show breast fat necrosis

A

ultrasound or mammogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is breast fat necrosis managed

A
  • histology via fine needle aspiration or core biopsy to exclude breast cancer as it may mimic it
  • after excluding, manage conservatively
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is mammary duct ectasia

A
  • benign conditions where there is dilation of the large breast ducts
  • common in menopause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which group of women are at a higher risk for developing mammary duct ectasia

A
  • menopausal women
  • smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How may mammary duct ectasia present

A
  • tender lumps around areola
  • thick nipple discharge from several ducts - green/ grey/ white
  • slit like nipple retraction/ inversion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is mammary duct ectasia managed

A
  • Reassurance after excluding cancer
  • supportive bra and warm compresses for mastalgia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is a breast abscess

A

collection of pus within the breast usually caused by bacterial infection (mc s.aureus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the two types of breast abscess

A
  • lactational abscess (associated with breastfeeding)
  • Non-lactational abscess (unrelated to breastfeeding)
24
Q

Give 3 RFs for breast abscesses and infective mastitis

A
  • smoking
  • breastfeeding
  • breast cancer
25
Q

Give 3 common causative bacteria for bacterial abscesses

A
  • staph aureus (mc)
  • streptococcal species
  • anaerobic bacteria
26
Q

How does a breast abscess present

A
  • swollen, fluctuant, tender breast lump
  • red and hot swelling
  • pain
27
Q

How may infective mastitis present

A
  • nipple changes
  • purulent nipple discharge
  • painful, tender, red hot breast
  • fever, and general malaise
  • may precede development of an abscess
28
Q

How is mastitis managed

A
  • first line: continue breastfeeding
  • analgesia and warm compress
  • antibiotics indicated if effective milk removal has not improved symptoms within 12-24hrs
  • antibiotics - oral flucloxacillin 10-14d
  • non-lactational: treat underlying cause
29
Q

How is a breast abscess managed

A
  • referral
  • broad spec antibiotics
  • ultrasound guided aspiration
30
Q

RFs for breast cancer

A
  • BRCA1 and BRCA2 genes
  • FHx (1st degree relative)
  • nulliparity
  • early menarche and late menopause
  • combined HRT
  • COCP
  • obesity
  • p53 gene mutations
31
Q

State the 4 common types of breast cancer

A
  • Invasive ductal carcinoma - no special type (mc)
  • Invasive lobular carcinoma
  • Ductal carcinoma-in-situ (DCIS)
  • Lobular carcinoma-in-situ (LCIS)
32
Q

Give 4 rarer types of breast cancer

A
  • Medullary breast cancer
  • Mucinous (mucoid or colloid) breast cancer
  • Paget’s disease of the nipple
  • Inflammatory breast cancer
33
Q

Describe ductal carcinoma in situ

A
  • Pre-cancerous or cancerous epithelial cells of the breast ducts
  • Localised to a single area
  • Often picked up by mammogram screening
  • Potential to spread locally over years
  • Potential to become an invasive breast cancer
34
Q

Describe lobular carcinoma in situ

A

*A pre-cancerous condition occurring typically in pre-menopausal women
* Usually asymptomatic and undetectable on a mammogram
* Usually diagnosed incidentally on a breast biopsy
* Often managed with close monitoring

35
Q

Describe invasive ductal carcinoma

A
  • no special type, where it is not more specifically classified
  • Originate in cells from the breast ducts
  • 80% of invasive breast cancers fall into this category
  • Can be seen on mammograms
36
Q

Describe invasive lobular carcinomas

A
  • Originate in cells from the breast lobules
  • Not always visible on mammograms
37
Q

Cause of inflammatory breast cancers

A

cancerous cells block the lymph drainage resulting in an inflamed appearance of the breast

38
Q

Features of inflammatory breast cancer

A
  • progressive, erythema and oedema of the breast
  • Swollen, warm, tender breast with pitting skin
  • absence of signs of infection
  • Does not respond to antibiotics
  • Worse prognosis than other breast cancers
39
Q

Describe Paget’s disease of the nipple

A
  • eczematoid change of the nipple
  • Reddening and thickening of nipple and areola
  • May represent DCIS or invasive breast cancer
  • Requires biopsy, staging and treatment
40
Q

Describe the NHS breast cancer screening programme

A

offers a mammogram every 3 years to women age 50-70 years

41
Q

What are the criteria for referring high risk breast cancer patients based on family history

A
  • A first-degree relative with breast cancer under 40 years
  • A first-degree male relative with breast cancer
  • A first-degree relative with bilateral breast cancer, first diagnosed under 50 years
  • Two first-degree relatives with breast cancer
42
Q

Clinical features of breast cancer

A
  • Lumps that are hard, irregular, painless or fixed in place
  • Lumps may be tethered to the skin or the chest wall
  • Nipple retraction
  • Skin dimpling or oedema
  • Lymphadenopathy, particularly in the axilla
43
Q

What is the criteria for a two-week wait referral for suspected breast cancer

A

Refer:
* An unexplained breast lump in patients aged 30 or above
* Unilateral nipple changes in patients aged 50 or above (discharge, retraction or other changes)
Consider:
* aged 30 and over with an unexplained lump in the axilla
* Skin changes suggestive of breast cancer

44
Q

How is breast cancer diagnosed

A
  • triple assessment: clinical assessment, imaging and biopsy
  • imaging - ultrasound (<35y) or mammogram (>35y)
  • fine needle aspiration or core biopsy
  • lymph node assessment - USS
45
Q

Give 4 notable locations that breast cancer metastasises to

A
  • Lungs
  • Liver
  • Bones (mc)
  • Brain
46
Q

How is management determined before breast cancer surgery?

A

By presence/absence of axillary lymphadenopathy:
* no palpable lymphadenopathy - pre-operative axillary USS before primary surgery
* if negative - sentinel node biopsy to assess the nodal burden
* palpable lymphadenopathy - axillary node clearance (radiotherapy) is indicated at primary surgery

47
Q

What complications can arise from axillary node clearance?

A

arm lymphoedema and functional arm impairment

48
Q

Describe the surgical management of breast cancer

A
  • mastectomy
  • wide local excision
  • breast reconstruction - delayed or immediate
49
Q

When is wide-local excision indicated for breast cancer surgery?

A
  • solitary lesion
  • peripheral tumour
  • small lesion in large breast
  • DCIS <4cm
50
Q

When is mastectomy indicated for breast cancer surgery?

A
  • multifocal tumour
  • central tumour
  • large lesion in small breast
  • DCIS >4cm
51
Q

Describe how radiotherapy is used in the management of breast cancer

A

Whole breast radiotherapy is recommended after a woman has had a wide-local excision as this may reduce the risk of recurrence

52
Q

Describe how hormonal treatments are used to manage breast cancer

A
  • adjuvant hormonal therapy is offered to patients with oestrogen-receptor positive breast cancer
  • pre- and peri-menopausal women: tamoxifen
  • postmenopausal women: aromatase inhibitor - e.g. anastrozole or letrozole
    each given for 5-10 years
53
Q

Give 3 side effects of tamoxifen

A
  • increased risk of endometrial cancer
  • increased risk of VTE
  • menopausal symptoms
54
Q

Describe how biological therapy is used in the management of breast cancer

A
  • trastuzumab (Herceptin) is used in patients with HER2 positive breast cancer
  • Pertuzumab (Perjeta) and Neratinib (Nerlynx) are others
55
Q

How is chemotherapy used in the management of breast cancer

A
  • Neoadjuvant therapy – intended to shrink the tumour before surgery
  • Neoadjuvant FEC-D chemotherapy if nodal involvement
  • Adjuvant chemotherapy – given after surgery to reduce recurrence
56
Q

What are the options for breast reconstruction following a mastectomy

A
  • Breast implants
  • Flap reconstruction (using tissue from another part of the body to reconstruct the breast)
57
Q

What are some issues with a synthetic breast implant

A
  • feels unnatural: cold, less mobile, static size and shape
  • hardening
  • leakage
  • shape change over time